X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercebiotech.com/biotech/genentech-didnt-get-it-right-diversity-critical-graduate-alzheimers-program-theyre-trying
https://www.fiercebiotech.com/biotech/genentech-ac-immune-crenezumab-failed-trial-alzheimers-aaic-conference-ceo-pfiefer
https://www.fiercebiotech.com/biotech/fierce-nextgen-despite-another-key-trial-failure-alzheimers-therapy-developers-find-reason
https://pharmaphorum.com/news/another-amyloid-miss-in-alzheimers-as-roches-crenezumab-fails-trial/
https://ir.acimmune.com/news-releases/news-release-details/ac-immune-provides-update-alzheimers-prevention-initiative-study
https://endpts.com/shehnaaz-suliman-dives-back-into-alzheimers-at-alector-pyxis-recruits-springworks-founder-lara-sullivan-as-ceo/
https://endpts.com/investors-lost-big-as-alzheimers-rd-went-over-the-cliff-in-2019-will-they-ever-come-back/
https://pharmaphorum.com/news/pharma-companies-clear-the-rd-decks-in-q4/
https://www.biospace.com/article/is-biogen-s-aducanumab-for-alzheimer-s-the-holy-grail-or-cold-fusion-/
https://www.reuters.com/article/us-roche-hldg-alzheimers-ac-immune/roche-ac-immune-drop-alzheimer-drug-trials-after-setback-idUSKCN1PO0GT
https://www.reuters.com/article/us-roche-hldg-alzheimers-ac-immune/roche-drops-alzheimer-drug-trials-after-setback-idUSKCN1PO0GT
https://www.fiercebiotech.com/biotech/roche-halts-phase-3-anti-abeta-alzheimer-s-trials-for-futility
Market Place
Share 
